Fresenius SE & Co. KGaA

Investor News 2005

09.12.2005	Fresenius obtained antitrust approval to acquire HELIOS Kliniken and the business of Clinico
	Text as PDF file
01.12.2005	Fresenius successfully completes capital increase
	Text as PDF file
15.11.2005	Fresenius fixes final subscription prices for new shares
	Text as PDF file
03.11.2005	Excellent financial results in the 1st-3rd quarter of 2005; full-year outlook confirmed
	Text as PDF file
25.10.2005	Fresenius resolves on capital increase and defines terms
	Text as PDF file
14.10.2005	Fresenius continues profitable growth
	Text as PDF file
15.08.2005	Extraordinary General Meeting of Fresenius Medical Care AG on August 30, 2005; Voting of Fresenius AG
	Text as PDF file
04.08.2005	First half of 2005: Fresenius achieves excellent financial results and raises full-year earnings outlook
	Text as PDF file
01.07.2005	Changes to Fresenius AG’s corporate credit ratings
	Text as PDF file
18.05.2005	ASCO-Meeting: Fresenius Biotech presents clinical trial results of new antibodies at the world’s largest cancer convention
	Text as PDF file
04.05.2005	First quarter 2005 and Fresenius Medical Care transactions
	Text as PDF file
16.03.2005	Fresenius Kabi closed acquisition of I.V. drug company Labesfal
	Text as PDF file
15.03.2005	Fresenius announces changes to the Management Board
	Text as PDF file
02.03.2005	Fresenius Kabi strengthens position in China – increases stake in joint venture from 65 % to 100 %
	Text as PDF file
24.02.2005	Excellent business performance in 2004; 12th consecutive dividend increase proposed; Positive outlook for 2005: 15-20 % net income growth projected
	Text as PDF file
07.01.2005	Fresenius Kabi continues growth strategy and acquires I.V. drug company
	Text as PDF file
06.01.2005	Immune Suppressive ATG-Fresenius S Receives Fast Track Status in the U.S. - First Patient Recruited in Clinical Trial
	Text as PDF file

Home > Investor Relations > News > Investor News > 2005